Progesterone Supplementation in Threatened Abortion

PHASE4CompletedINTERVENTIONAL
Enrollment

190

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions
Threatened AbortionProgesterone Resistance
Interventions
DRUG

Progesterone

received rectal progesterone suppositories 400 mg once daily

DRUG

Placebos

received placebo suppositories rectally once daily.

Trial Locations (1)

Unknown

Ayman Shehata Dawood, Tanta

All Listed Sponsors
lead

Tanta University

OTHER

NCT03930212 - Progesterone Supplementation in Threatened Abortion | Biotech Hunter | Biotech Hunter